Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Clinical Research Associates Inc

Verified

Basic Information

Site Overview

Source: Human-provided.

Clinical Research Associates (CRA), Nashville, Tennessee, is an independent clinical research site with more than three decades of experience conducting Phase II–IV clinical trials for pharmaceutical, biotechnology, and medical device sponsors. Established in 1990, the site has completed hundreds of clinical studies across a broad range of therapeutic areas including endocrinology, diabetes, vaccines, cardiovascular disease, women's health, smoking cessation, obesity, neurology, and infectious diseases. CRA operates with a dedicated team of investigators, research coordinators, regulatory specialists, and patient recruitment professionals, enabling efficient study start-up, enrollment, and data management. The site is recognized for its strong patient retention, community-based recruitment strategies, and participation in pivotal vaccine and metabolic disease research, making it a well-established partner for industry-sponsored and investigator-initiated clinical trials.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Doctor

Business Subcategory

Source: Human-provided. Doctor
Source: Trial-derived.
41Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
7Active Trials
Source: Trial-derived.
30Completed Trials
Source: Trial-derived.
41Unique Conditions
Source: Trial-derived.
19Unique Sponsors

Conditions

Source: Trial-derived. Obesity (5)Source: Trial-derived. Type 2 Diabetes (4)Source: Trial-derived. COVID-19 (3)Source: Trial-derived. Diabetes Mellitus, Type 2 (2)Source: Trial-derived. Endometriosis (2)Source: Trial-derived. Heartburn (2)Source: Trial-derived. Influenza (2)Source: Trial-derived. Influenza, Human (2)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (9)Source: Trial-derived. Pfizer (6)Source: Trial-derived. BioNTech SE (4)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. Phathom Pharmaceuticals, Inc. (4)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Kissei Pharmaceutical Co., Ltd. (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PBMC isolation & cryopreservation

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. ELISpot assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Ophthalmological retinopathy examination
Source: AI-inferred. Virus neutralisation assay